0001493152-23-000130.txt : 20230103
0001493152-23-000130.hdr.sgml : 20230103
20230103162022
ACCESSION NUMBER: 0001493152-23-000130
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221229
FILED AS OF DATE: 20230103
DATE AS OF CHANGE: 20230103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KOSKI ROBERT C
CENTRAL INDEX KEY: 0001234880
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32188
FILM NUMBER: 23502363
MAIL ADDRESS:
STREET 1: 1500 W UNIVERSITY PARKWAY
CITY: SARASOTA
STATE: FL
ZIP: 34243
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORAGENICS INC
CENTRAL INDEX KEY: 0001174940
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 593410522
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4902 EISENHOWER BLVD
STREET 2: SUITE 125
CITY: TAMPA
STATE: FL
ZIP: 33634
BUSINESS PHONE: 8132867900
MAIL ADDRESS:
STREET 1: 4902 EISENHOWER BLVD
STREET 2: SUITE 125
CITY: TAMPA
STATE: FL
ZIP: 33634
4
1
ownership.xml
X0306
4
2022-12-29
0
0001174940
ORAGENICS INC
OGEN
0001234880
KOSKI ROBERT C
4902 EISENHOWER BOULEVARD
TAMPA
FL
33634
1
0
0
0
Common Stock
2022-12-29
4
S
0
36648
0.1060
D
176191
D
Common Stock
2022-12-30
4
S
0
42357
0.1055
D
1102295
I
See footnote
The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1020 to $0.1121 and $0.1026 to $0.1096 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Shares owned directly by Robert C. Koski, a director of the Company.
Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
/s/ Mark A. Catchur, as Attorney-in-Fact for Robert C. Koski
2023-01-03